WHITNEY CANNON: Open Payments
NPI 1548719420 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 23 payments from 6 companies in 2025. Trend: 2023 $206 · 2024 $185 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $210 |
| ABBVIE INC. | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Abbott Laboratories | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
Products named: LEQVIO, VRAYLAR, GVOKE HYPOPEN, XIFAXAN, PROCLAIM, Cologuard Collection Kit.
Industry payments across AL — which companies pay providers there.
